SJS Investment Consulting Inc.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1894302 SYLVANIA, OH

Position in BCRX

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$10,830

+$10,697 QoQ

Shares Held

1,083

+7635.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#281

of 316 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SJS Investment Consulting Inc. holds $550,595 across 35 Drug Manufacturers - Specialty & Generic names. BCRX ranks #10 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HROW	Harrow, Inc.	6,073	$257,920
2	ZTS	Zoetis Inc.	770	$55,331
3	NBIX	Neurocrine Biosciences Inc	255	$42,977
4	TAK	Takeda Pharmaceutical Co Ltd	2,285	$36,627
5	UTHR	UNITED THERAPEUTICS Corp	54	$29,258
6	ELAN	Elanco Animal Health Inc	1,180	$29,039
7	VTRS	Viatris Inc	895	$14,212
8	HIMS	Hims & Hers Health, Inc.	348	$12,064

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,830	1,083	+7635.7%	Shares	Defined	2026-07-22
2026-03-31	$133	14	0.0%	Shares	Defined	2026-04-23
2025-12-31	$109	14	-30.0%	Shares	Sole	2026-01-21
2024-03-31	$101	20	+11.1%	Shares	Defined	2024-04-18
2023-12-31	$107	18	-28.0%	Shares	Defined	2024-01-16
2023-09-30	$177	25	+78.6%	Shares	Defined	2023-10-17
2023-06-30	$98	14	0.0%	Shares	Defined	2023-07-13
2023-03-31	$116	14	-46.2%	Shares	Defined	2023-04-20
2022-12-31	$298	26	+116.7%	Shares	Defined	2023-01-23
2022-09-30	$151	12	+500.0%	Shares	Defined	2022-10-13
2022-03-31	$32	2	—	Shares	Sole	2022-05-05
No filing history on record for this holder in this stock.